Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods of reducing toxicity induced by Amyloid beta (A-beta) oligomers using antibodies specific to A-beta oligomers

Methods of reducing toxicity induced by Amyloid beta (A-beta) oligomers using antibodies specific to A-beta oligomers

US Patent 12071472 · Granted Aug 27, 2024

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Conformation-specific epitopes in alpha-synuclein, antibodies thereto and method2025
Conformation-specific epitopes in alpha-synuclein, antibodies thereto and method2025
Conformation-specific epitopes in alpha-synuclein, antibodies thereto and method2025
Humanized antibodies binding to amyloid-beta (A-beta)2025
Humanized antibodies binding to amyloid-beta (A-beta)2025
Humanized antibodies binding to amyloid-beta (A-beta)2025
Humanized antibodies binding to amyloid-beta (A-beta)2025
Humanized antibodies binding to amyloid-beta (A-beta)2025
N-terminal epitopes in amyloid beta and conformationally-selective antibodies th2024
N-terminal epitopes in amyloid beta and conformationally-selective antibodies th2024
Cyclic compound/peptide comprising an A-beta15-18 peptide and a linker that is c2024
Cyclic compound/peptide comprising an A-beta15-18 peptide and a linker that is c2024